JP2020535832A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535832A5 JP2020535832A5 JP2020519092A JP2020519092A JP2020535832A5 JP 2020535832 A5 JP2020535832 A5 JP 2020535832A5 JP 2020519092 A JP2020519092 A JP 2020519092A JP 2020519092 A JP2020519092 A JP 2020519092A JP 2020535832 A5 JP2020535832 A5 JP 2020535832A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- tcr
- human
- antigen
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023220106A JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762568339P | 2017-10-05 | 2017-10-05 | |
| US62/568,339 | 2017-10-05 | ||
| PCT/US2018/052432 WO2019070435A1 (en) | 2017-10-05 | 2018-09-24 | METHODS FOR SELECTIVE EXPANSION OF CELLS EXPRESSING A TCR WITH A CONSTANT MURINE REGION |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023220106A Division JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020535832A JP2020535832A (ja) | 2020-12-10 |
| JP2020535832A5 true JP2020535832A5 (cg-RX-API-DMAC10.html) | 2021-11-04 |
| JP7867764B2 JP7867764B2 (ja) | 2026-06-01 |
Family
ID=63841049
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519092A Active JP7867764B2 (ja) | 2017-10-05 | 2018-09-24 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
| JP2023220106A Active JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023220106A Active JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3786178A1 (en) | 2019-08-30 | 2021-03-03 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Tcr constructs specific for ebv-derived antigens |
| CA3202874A1 (en) * | 2020-12-22 | 2022-06-30 | Carsten LINNEMANN | Peptide markers to track genetically engineered cells |
| JP2024507929A (ja) | 2021-02-25 | 2024-02-21 | アラウノス セラピューティクス インコーポレイテッド | 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法 |
| WO2023150562A1 (en) | 2022-02-01 | 2023-08-10 | Alaunos Therapeutics, Inc. | Methods for activation and expansion of t cells |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993011794A1 (en) | 1991-12-13 | 1993-06-24 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| US6063983A (en) | 1995-09-05 | 2000-05-16 | The General Hospital Corporation | Monoclonal lymphocytes and methods of use |
| DE19905048A1 (de) | 1999-02-08 | 2000-08-10 | Gsf Forschungszentrum Umwelt | Verwendung depletorisch oder mitogen wirkender Antikörper in der Immuntherapie |
| JP2003274960A (ja) * | 2000-02-03 | 2003-09-30 | Japan Science & Technology Corp | 可溶性ｔ細胞受容体タンパク質およびその作成方法 |
| JP2003276960A (ja) * | 2002-03-26 | 2003-10-02 | Mitsubishi Electric Corp | エレベーター制御システム |
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| KR101131297B1 (ko) * | 2003-11-10 | 2012-03-30 | 알토 바이오사이언스 코포레이션 | 가용성 티씨알 분자 및 이용 방법 |
| US20090304657A1 (en) * | 2006-05-03 | 2009-12-10 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Chimeric t cell receptors and related materials and methods of use |
| CA2674445C (en) | 2007-01-12 | 2016-06-07 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Gp100-specific t cell receptors and related materials and methods of use |
| US8785601B2 (en) | 2009-01-28 | 2014-07-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| US9345748B2 (en) | 2010-09-21 | 2016-05-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-SSX-2 T cell receptors and related materials and methods of use |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| ES2835200T3 (es) | 2012-05-22 | 2021-06-22 | Us Health | Uso médico de células que comprenden receptores de células T anti-NY-ESO-1 |
| US9879065B2 (en) * | 2012-09-14 | 2018-01-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors recognizing MHC class II-restricted MAGE-A3 |
| CN110511960B (zh) * | 2013-07-15 | 2023-05-23 | 美国卫生和人力服务部 | 抗人乳头瘤病毒16 e6 t细胞受体 |
| PT3149031T (pt) | 2014-05-29 | 2020-03-25 | Us Health | Receptores de células t anti-e7 do papilomavírus humano 16 |
| CN107075479A (zh) * | 2014-10-02 | 2017-08-18 | 美国卫生和人力服务部 | 分离对癌症特异性突变具有抗原特异性的t细胞的方法 |
| EP3220928B1 (en) * | 2014-11-20 | 2022-10-05 | UMC Utrecht Holding B.V. | A method of obtaining a preparation enrichmed in engineered t cells with exogenous immune receptors |
| SG10201913978RA (en) | 2014-11-26 | 2020-03-30 | The United States Of America As Represented By The Secretary | Anti-mutated kras t cell receptors |
| SG10201913868XA (en) | 2015-09-15 | 2020-03-30 | The United States Of America As Represented By The Secretary | T cell receptors recognizing hla-cw8 restricted mutated kras |
| DK3448882T3 (da) | 2016-04-26 | 2022-02-21 | Us Health | Anti-kk-lc-1-t-cellereceptorer |
| SG11201900654QA (en) | 2016-08-02 | 2019-02-27 | Us Health | Anti-kras-g12d t cell receptors |
-
2018
- 2018-09-24 US US16/652,948 patent/US12227554B2/en active Active
- 2018-09-24 WO PCT/US2018/052432 patent/WO2019070435A1/en not_active Ceased
- 2018-09-24 AU AU2018345400A patent/AU2018345400B2/en active Active
- 2018-09-24 JP JP2020519092A patent/JP7867764B2/ja active Active
- 2018-09-24 IL IL273698A patent/IL273698B2/en unknown
- 2018-09-24 FI FIEP18786145.5T patent/FI3692140T3/fi active
- 2018-09-24 CA CA3077595A patent/CA3077595A1/en active Pending
- 2018-09-24 KR KR1020207012314A patent/KR102757789B1/ko active Active
- 2018-09-24 ES ES18786145T patent/ES2960313T3/es active Active
- 2018-09-24 EP EP18786145.5A patent/EP3692140B1/en active Active
- 2018-09-24 SG SG11202003112QA patent/SG11202003112QA/en unknown
- 2018-09-24 CN CN201880076862.9A patent/CN111417720B/zh active Active
- 2018-09-24 EP EP23185846.5A patent/EP4269595A3/en active Pending
- 2018-09-24 MA MA050748A patent/MA50748A/fr unknown
-
2023
- 2023-12-26 JP JP2023220106A patent/JP7747724B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lonez et al. | Allogeneic CAR-T therapy technologies: has the promise been met? | |
| Kervevan et al. | Role of CD4+ T cells in the control of viral infections: recent advances and open questions | |
| Zhu et al. | CD4 T helper cell subsets and related human immunological disorders | |
| Agac et al. | Host responses to respiratory syncytial virus infection | |
| Selck et al. | Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation | |
| Palatella et al. | The dark side of Tregs during aging | |
| JP2021511790A5 (cg-RX-API-DMAC10.html) | ||
| Sun et al. | Is there natural killer cell memory and can it be harnessed by vaccination? NK cell memory and immunization strategies against infectious diseases and cancer | |
| JP2016539929A5 (cg-RX-API-DMAC10.html) | ||
| JP2023164900A5 (cg-RX-API-DMAC10.html) | ||
| JP2019536461A5 (cg-RX-API-DMAC10.html) | ||
| JP2023508740A5 (cg-RX-API-DMAC10.html) | ||
| JP2016509840A5 (cg-RX-API-DMAC10.html) | ||
| JP2004536615A5 (cg-RX-API-DMAC10.html) | ||
| Allegra et al. | Lymphocyte subsets and inflammatory cytokines of monoclonal gammopathy of undetermined significance and multiple myeloma | |
| JP2010505830A5 (cg-RX-API-DMAC10.html) | ||
| CN102911918A (zh) | 一种基因工程细胞及其在nk细胞扩增中的应用 | |
| JP2022505194A5 (cg-RX-API-DMAC10.html) | ||
| JP2012505665A5 (cg-RX-API-DMAC10.html) | ||
| JP2011519869A5 (cg-RX-API-DMAC10.html) | ||
| Forrest et al. | NK cell memory to cytomegalovirus: implications for vaccine development | |
| JP2017508523A5 (cg-RX-API-DMAC10.html) | ||
| JP2013505296A5 (cg-RX-API-DMAC10.html) | ||
| JP2001149069A (ja) | ナチュラルキラー細胞の増殖方法 | |
| DE60332377D1 (de) | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden |